Unique ID issued by UMIN | UMIN000003560 |
---|---|
Receipt number | R000004083 |
Scientific Title | Multi-centered Liraglutide add-on SU or diet alone study in West-Tokyo area |
Date of disclosure of the study information | 2010/10/15 |
Last modified on | 2010/05/02 13:07:46 |
Multi-centered Liraglutide add-on SU or diet alone study in West-Tokyo area
Liraglutide study adding-on SU or diet alone
Multi-centered Liraglutide add-on SU or diet alone study in West-Tokyo area
Liraglutide study adding-on SU or diet alone
Japan |
Type2 diabetes
Medicine in general |
Others
NO
1)To observe of its safety and effectiveness
2)To observe HbA1c improvement 6 months after the administration of Liraglutide
3)To observe the difference of effectiveness between SUs.
4) To observe the control after withdrawal of Liraglutide.
Safety,Efficacy
HbA1c
Body weight, achievement of the goal, pancreas function, medications, AE, withdrawal rate, blood pressure, waist circumference, cholesterols, QOL
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
Injection of Liraglutide, withdrawal of Liraglutide after achievement of glycemic control HbA1c<6.1%.
Not applicable |
Not applicable |
Male and Female
HbA1c more than 6.5%, Type 2 diabetes, diet and exercise alone or prescribed surfonyl urea, 20 year-old or older, capable of injecting by themselves.
Serious hypoglycemia, serious diabetic retinopathy, serious heart failure, with malignant tumor, pregnant, prescribed TZD or glinide.
80
1st name | |
Middle name | |
Last name | Takaichi Miyakawa, Yuko Watanabe, Hitomi Fujii |
Tama-center Mirai Clinic
Internal Medicine
1-38-1F Ochiai Tama-city, Tokyo
042-316-8570
1st name | |
Middle name | |
Last name | Takaichi Miyakawa, Yuko Watanabe, Hitomi Fujii |
Tama-center Mirai Clinic
Internal Medicine
1-38-1F Ochiai Tama-city, Tokyo
042-316-8570
irb-mirai@tama-mirai.com
Tama-center Mirai Clinic
none
Self funding
NO
2010 | Year | 10 | Month | 15 | Day |
Unpublished
Preinitiation
2010 | Year | 04 | Month | 01 | Day |
2010 | Year | 04 | Month | 01 | Day |
HbA1c and also the influence over body weight, serum cholesterol, and blood pressure will be observed. Also withdrawal rate and glycemic control after achievement HbA1c less than 6.1% will be observed.
2010 | Year | 05 | Month | 02 | Day |
2010 | Year | 05 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004083
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |